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Abstract 
Background 
Total kidney volume (TKV) is an approved early prognostic marker of progression in 
autosomal dominant polycystic kidney disease. The approval of tolvaptan for patients 
with rapid disease progression in Europe requires accurate patient stratification. Current 
methods of TKV measurement rely on manual segmentation which is time consuming, 
restricting its clinical use. To address this important clinical challenge we report the 
development and performance of a semi-automated method (Sheffield TKV tool) to 
measure TKV in patients with this disease. 
Methods 
1.5T MRI scans were acquired (Siemens Avanto) in 61 adult patients with autosomal 
dominant polycystic kidney disease. Manual segmentation of the kidneys was performed 
on T2 true fast imaging with steady state precession MRI. Computational semi-
automated segmentation methods were tested in a subgroup of ten patients and the 
optimum method used in all 61 cases to measure TKV (mL). Manual and semi-
automated results were compared by Bland±Altman analyses. Processing time for 
manual and semi-automated methods were recorded. 
Findings 
Our cohort consisted of 29 men and 32 women (mean age 45 years, SD 14). Estimated 
GFR (eGFR) in patients within 1 month of the MRI ranged between 32 and 138 mL/min. 
TKV measured by manual segmentation ranged between 258 and 3680 mL. The 
Sheffield TKV tool performed optimally for calculating TKV, reporting accurate results in 
80% of cases compared with manual TKV. Inaccuracies were associated with erroneous 
inclusion of blood vessels, the renal hilum, or leakage into neighbouring tissues, and 
overall were more frequent in smaller kidneys. Processing time for TKV with the 
Sheffield TKV tool was 2±5 min compared with 20±30 min for manual segmentation. 
Interpretation 
We describe a new rapid, semi-automated method for measuring TKV on MRI which 
should be a useful tool for evaluating patients with autosomal dominant polycystic kidney 
disease. We plan to optimise MRI acquisition sequences and extract the renal hilar 
volume to improve performance of the Sheffield TKV tool and validate it in another 
population with autosomal dominant polycystic kidney disease, with the ultimate aim of 
using it in clinical practice. 
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